COVID-19 mRNA vaccines drive differential antibody Fc-functional profiles in pregnant, lactating, and nonpregnant women
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
Pregnant and lactating women develop distinct antibody Fc profiles in response to the mRNA-1273 and BNT162b2 vaccines compared to nonpregnant women.
Article activity feed
-
-
SciScore for 10.1101/2021.04.04.438404: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: Eligible women were: (n=84 pregnant; n=31 lactating; or n=16 non-pregnant and of reproductive age (18-45); greater than or equal to 18 years old, able to provide informed consent, and receiving the COVID-19 vaccine.
IRB: The study was approved by the MGH Institutional Review Board.Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable Eligible women were: (n=84 pregnant; n=31 lactating; or n=16 non-pregnant and of reproductive age (18-45); greater than or equal to 18 years old, able to provide informed consent, and receiving the COVID-19 vaccine. Cell Line Authentication not detected. Table 2: Resources
… SciScore for 10.1101/2021.04.04.438404: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: Eligible women were: (n=84 pregnant; n=31 lactating; or n=16 non-pregnant and of reproductive age (18-45); greater than or equal to 18 years old, able to provide informed consent, and receiving the COVID-19 vaccine.
IRB: The study was approved by the MGH Institutional Review Board.Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable Eligible women were: (n=84 pregnant; n=31 lactating; or n=16 non-pregnant and of reproductive age (18-45); greater than or equal to 18 years old, able to provide informed consent, and receiving the COVID-19 vaccine. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Antibody-dependent neutrophil phagocytosis: Antibody-dependent neutrophil phagocytosis was measured by a flow cytometry-based assay (48). Antibody-dependent neutrophil phagocytosissuggested: NoneAntibody-dependentsuggested: NonePE-coupled mouse anti-human detection antibodies (Southern Biotech) were used to detect antigen-specific antibody binding. anti-human detection antibodies (Southern Biotech)suggested: Noneantigen-specificsuggested: NoneExperimental Models: Cell Lines Sentences Resources Cell lines: THP-1 cells used in phagocytic assays were grown in RPMI media supplemented with 10% FBS, 5% penn/strep, 5% L-glutamine, 5% HEPES buffer (pH 7.2) and 0.5% 2-Mercaptoethanol, and maintained at 2.5×105 cells/ml. THP-1suggested: NoneSoftware and Algorithms Sentences Resources Univariate statistical analysis: For univariate data analysis, statistics were run using GraphPad Prism version 8.0. GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)Multivariate analysis: Multivariate analyses were performed in R (version 4.0.0) and Python (version 3.9.1). Pythonsuggested: (IPython, RRID:SCR_001658)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
